Donald Gleason Conference on Genitourinary Malignancies

This conference brings together top-notch faculty to share updates and best practices in the interest of advancing our collective knowledge related to early diagnosis, proper staging, and effective treatment of urologic cancers.

This course is planned and hosted by the University of Minnesota Department of Urology. For more information contact Casey Pratt, [email protected]. 

1. Identify new approaches for diagnosis and treatment of urologic cancers.
2. Describe the latest therapeutic interventions for urologic cancers.
3. Describe emerging concepts in treatment of advanced urologic cancers.
4. Explain the biology of urologic cancers.
5. Review strategies to discuss with patients the risks and benefits of new and evolving treatment options for urologic cancers.

Early Registration Rate - Now through July 28, 2023

• Physicians $150
• APPs and Nurses $125
• Medical Industry Professionals $200

Regular Registration Rate - On or after July 29, 2023

• Physicians $200
• APPs and Nurses $150
• Medical Industry Professionals $250

On-site registration will be allowed as space permits. All on-site registrants must use their own device to submit their registration and payment by credit card via CE Portal (cash/check not accepted). Registration through CE Portal is required even if attendance is free-of-charge. Special needs, such as dietary restrictions, lactation room, etc., should be requested in advance. These requests cannot always be honored on site.

Cancellation Policy
In the event you need to cancel your registration, the registration fee, less a $50 administrative fee, will be refunded if you notify us by 4:30 p.m. Central Time on September 15, 2023. No refunds will be made after this date.

Credit Designation Statements

American Medical Association (AMA)
The University of Minnesota, Interprofessional Continuing Education designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC)
This activity is awarded up to 5.5 ANCC contact hours.

American Academy of Physician Assistants (AAPA)
University of Minnesota, Interprofessional Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other Healthcare Professionals
Other healthcare professionals who participate in this CE activity may submit their certificate of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

The Graduate Hotel
615 Washington Ave. SE
Minneapolis, MN 55414

Mitigation of Relevant Financial Relationships

Faculty Member Information

Role in activity

Name of Ineligible Company(s) / Nature of Relationship(s)

Christopher Warlick, MD, PhD
University of Minnesota

Course Director, Faculty

Advisor-Francis Medical|Grant or research support-Exact Sciences

Kathy Borchert, APRN
MHealth Fairview

Faculty

Nothing to disclose

Ryan Haggart, MD

Faculty

Justin Hwang, PhD
Hematology, Oncology and Transplantation

Faculty

Nothing to disclose

Gregory J. Metzger, PhD
University of Minnesota

Faculty

Nothing to disclose

Tanner Miest, MD, PhD
University of Minnesota

Faculty

Nothing to disclose

Sami Mostafa, MD
University of Minnesota

Faculty

Pooja Srikanth, MD

Faculty

Minghao Zhong, MD, PhD
University of Minnesota

Faculty

Nothing to disclose

Hamed Ahmadi, MD
University of Minnesota

Faculty, Planning Committee Member

Nothing to disclose

Emmanuel S Antonarakis, MD
University of Minnesota

Faculty, Planning Committee Member

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Aadi Bioscience (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Aikido Pharma (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Amgen, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bayer (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Blue Earth Diagnostics|Grant or research support-Celgene Corporation (Relationship has ended)|Grant or research support-Clovis Oncology (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-CM Propel (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-EcoR1 (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Foundation Medicine (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Hookipa Pharma (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Ismar (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Janssen (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-KeyQuest Health (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-MacroGenics (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Menarini Silicon Biosystems (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Orion (Relationship has ended)|Royalties or Patent Beneficiary-Qiagen|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi S.A.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Tempus (Relationship has ended)|Advisor-UroWebinar (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Z-Alpha

Scott Dehm, PhD
University of Minnesota

Faculty, Planning Committee Member

Paid consultant-Oncternal Therapeutics|Paid consultant-Janssen (Any division) (Relationship has ended)|Paid consultant-Bristol-Myers Squibb Company|Grant or research support-Pfizer (Any division) (Relationship has ended)

Subodh K Regmi, MBBS, Assistant Professor
University of Minnesota

Faculty, Planning Committee Member

Nothing to disclose

Joseph Zabell, MD
University of Minnesota

Faculty, Planning Committee Member

Nothing to disclose

Maxine Simmons, RN
RNCC
M Health

Nurse Planner

Joshua Anderson, PA
University of Minnesota Physicians

Planning Committee Member

Nothing to disclose

Friday, September 29, 2023

If you have registered as an exhibitor and have questions, contact Casey Pratt, [email protected].